M&A / Deals GBL joins CVC in 10.7bn takeover bid for Recordati PharmaphorumA consortium of investors has made a 10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.Read full story pharminent May 22, 2026 (Last updated: May 22, 2026) Pharmaphorum A consortium of investors has made a 10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through. Read full story Post navigation Previous: Gilead Sciences completes Tubulis acquisition for $5bnNext: Gilead inks $140M API supply deal, tightening ties to Korean manufacturer Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026